| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/03/2013 | CN103181949A Oral preparation capable of calming and soothing nerves, and preparation method thereof |
| 07/03/2013 | CN103181941A Application of icariin or icarisid II in preparation of medicine for preventing and curing diabetic retinopathy |
| 07/03/2013 | CN103181936A Ginkgo flavone liposome oral emulsion formula and preparation method thereof |
| 07/03/2013 | CN103181932A Methods, pharmaceutical compositions and articles of manufacture for administering therapeutic cells to the animal central nervous system |
| 07/03/2013 | CN103181928A Application of methyl salicylate glucoside in prevention and/or treatment of Alzheimer disease |
| 07/03/2013 | CN103181916A Venlafaxine hydrochloride slow-release capsule and preparation method thereof |
| 07/03/2013 | CN103181914A Memantine hydrochloride sustained-release capsule and preparation method thereof |
| 07/03/2013 | CN103181913A 一种胡椒碱自乳化软胶囊及其制备方法 One kind of self-emulsifying soft capsules piperine and its preparation method |
| 07/03/2013 | CN103181905A Process for preparing pramipexole dihydrochloride tablets |
| 07/03/2013 | CN103181891A Andrographolide injection and preparation method thereof |
| 07/03/2013 | CN103181597A Ledum palustre detoxication health care liquid and preparation method thereof |
| 07/03/2013 | CN102657819B Drug combination for treating dysthymic disorder |
| 07/03/2013 | CN102657786B Drinking potion for treating mania |
| 07/03/2013 | CN102488826B Method for preparing freeze-dried oral preparation of spina date seed decoction |
| 07/03/2013 | CN102389446B Ginseng steaming method |
| 07/03/2013 | CN102274227B Application of tetrandrine in preparation of drug for prevention and/or treatment of depression |
| 07/03/2013 | CN102219783B Vilazodone hydrochloride and composition thereof |
| 07/03/2013 | CN102145105B Extract of the family dioscoreaceae and composition for preventing or treating peripheral neuropathy comprising the same |
| 07/03/2013 | CN102139023B Health-care tobacco-control type Chinese medicinal herb sucking product and preparation method |
| 07/03/2013 | CN102026988B 3-substituted propanamine compounds |
| 07/03/2013 | CN102018696B Skin external preparation containing lidocaine or pharmaceutical salt thereof |
| 07/03/2013 | CN101919830B Novel application of 2,4-dimethoxyl trans-stilbene |
| 07/03/2013 | CN101712675B Nitrogenous benzheterocycle derivate and application thereof in treating nervous and mental diseases |
| 07/03/2013 | CN101665536B Anti-vegf antibodies |
| 07/02/2013 | USRE44338 Amyloid plaque aggregation inhibitors and diagnostic imaging agents |
| 07/02/2013 | US8476405 Neuregulin variants and methods of screening and using thereof |
| 07/02/2013 | US8476314 Substance with sedative effect |
| 07/02/2013 | US8476286 Quinazoline derivatives which promote the release of parathyroid hormone |
| 07/02/2013 | US8476280 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| 07/02/2013 | US8476279 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 07/02/2013 | US8476275 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor |
| 07/02/2013 | US8476254 Methods for treating psychosis associated with interferson-α therapy |
| 07/02/2013 | US8476220 Biocompatible polymers, process for their preparation and compositions containing them |
| 07/02/2013 | US8475800 Phosphorylated derivatives of a U1-70K peptide and their use in the treatment of autoimmune pathologies |
| 07/02/2013 | US8475788 Methods of treating spinal cord injury and minimizing scarring |
| 07/02/2013 | US8475766 Dual specificity antibodies and methods of making and using |
| 07/02/2013 | CA2750209C Coated solid preparations of valproic acid |
| 07/02/2013 | CA2742946C Antioxidant |
| 07/02/2013 | CA2716918C Tricyclic derivatives as inhibitors of poly(adp-ribose)polymerase (parp) |
| 07/02/2013 | CA2687608C Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
| 07/02/2013 | CA2588293C Rasagiline orally disintegrating compositions |
| 07/02/2013 | CA2535483C Compositions and methods for reducing the risk of epileptic occurrence and/or for treatment of seizure disorders |
| 07/02/2013 | CA2533117C Combinations for the treatment of depression |
| 06/27/2013 | WO2013096870A1 Compositions and methods for treating amyotrophic lateral sclerosis |
| 06/27/2013 | WO2013096560A1 Excipient-free aerosol formulation |
| 06/27/2013 | WO2013095321A1 Heroin haptens, immunoconjugates and related uses |
| 06/27/2013 | WO2013095060A1 6-aminopyridine-3-ol derivatives or pharmaceutically acceptable salts thereof, and pharmaceutical composition containing same as active ingredients for preventing or treating diseases caused by angiogenesis |
| 06/27/2013 | WO2013094676A1 Hydroxymethylfurfural derivative |
| 06/27/2013 | WO2013093497A1 2 - (pyridin- 2yl) - 1, 7 -diaza- spiro [4.4] nonane- 6 -one compounds as voltage - gated sodium channels modulators |
| 06/27/2013 | WO2013093496A1 2 - (pyridin- 2yl) - 1, 7 -diaza-spiro [4.4] nonane- 6 -one compound as voltage-gated sodium channels modulator |
| 06/27/2013 | WO2013093122A2 Antibodies for the treatment and diagnosis of affective and anxiety disorders |
| 06/27/2013 | WO2013092893A1 Chemical compounds |
| 06/27/2013 | WO2013092589A1 Multiple unit pellet tablet formulation comprising an opioid |
| 06/27/2013 | WO2013092574A1 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals |
| 06/27/2013 | WO2013091900A1 Pipecolate-diketoamides for treatment of psychiatric disorders |
| 06/27/2013 | WO2013091773A1 Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators |
| 06/27/2013 | WO2013091539A1 Pyrrole six-membered heteroaryl ring derivative, preparation method therefor, and medicinal uses thereof |
| 06/27/2013 | WO2013091334A1 Use of rapamycin in preparing drugs for treating schizophrenia |
| 06/27/2013 | WO2013091282A1 Cajanine structure analogous compound, preparation method and use |
| 06/27/2013 | WO2013091008A1 Method of treating reduced ceruloplasmin functionality in the central nervous system |
| 06/27/2013 | WO2013062442A3 Composition for the treatment of multiple sclerosis (variants) |
| 06/27/2013 | WO2013055386A3 Application of 5-ht6 receptor antagonists for the alleviation of cognitive deficits of down syndrome |
| 06/27/2013 | WO2013038200A3 Neurodevelopmental disorders |
| 06/27/2013 | WO2013024474A8 Polymorphs of preladenant |
| 06/27/2013 | US20130165469 Novel neuromodulatory compounds |
| 06/27/2013 | US20130165466 Polymer conjugates of opioid antagonists |
| 06/27/2013 | US20130165457 Inhibitors of e1 activating enzymes |
| 06/27/2013 | US20130165430 Composition and method for compounded therapy |
| 06/27/2013 | US20130165429 Composition and method for compounded therapy |
| 06/27/2013 | US20130165375 Treatment of depressive disorders |
| 06/27/2013 | US20130164843 Method and medicament for inhibiting the expression of a given gene |
| 06/27/2013 | US20130164366 Method and medicament for inhibiting the expression of a given gene |
| 06/27/2013 | US20130164335 Methods and compositions for cellular drug release |
| 06/27/2013 | DE112011102411T5 Verfahren zur Behandlung von Aufmerksamkeits-Mangel-Hyperaktivitäts-Störung A method of treating Attention Deficit Hyperactivity Disorder |
| 06/27/2013 | CA2857977A1 Pyrrole six-membered heteroaryl ring derivative, preparation method thereof, and medicinal uses thereof |
| 06/27/2013 | CA2856964A1 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals |
| 06/27/2013 | CA2853779A1 Combination therapy with interferon and andrographolides for multiple sclerosis |
| 06/26/2013 | EP2607364A1 Tetraaza-cyclopenta[a]indenyl and their use as positive allosteric modulators |
| 06/26/2013 | EP2607358A1 Novel anti-inflammatory metabolite derived from omega-3-type fatty acid |
| 06/26/2013 | EP2607352A1 Pipecolate-diketoamides for treatment of psychiatric disorders |
| 06/26/2013 | EP2607348A2 Plasminogen Activator Inhibitor-1 Inhibitor |
| 06/26/2013 | EP2606886A1 Composition containing tetracyclic compound |
| 06/26/2013 | EP2606879A1 Multiple unit pellet tablet formulation comprising an opioid |
| 06/26/2013 | EP2606052A1 Nicotinic receptor compounds |
| 06/26/2013 | EP2606049A2 2,5-methano-and 2,5-ethano-tetrahydrobenzazepine derivatives and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| 06/26/2013 | EP2606043A1 Pyridazin derivatives as antagonists of the bradykinin b1 receptor |
| 06/26/2013 | EP2606033A1 Substituted cyclic carboxamide and urea derivatives as ligands of the vanilloid receptor |
| 06/26/2013 | EP2605789A2 Modified relaxin polypeptides and their uses |
| 06/26/2013 | EP2605776A1 Diazoxide for use in the treatment of amyotrophic lateral sclerosis (als) |
| 06/26/2013 | EP2605773A1 Treatment of cognitive disorders associated with abnormal dendritic spines using pkc activators |
| 06/26/2013 | EP2605771A1 Method of activating regulatory t cells with alpha-2b adrenergic receptor agonists |
| 06/26/2013 | EP2605757A2 Nalbuphine-based formulations and uses thereof |
| 06/26/2013 | EP2605658A1 Spiroxazolidinone compounds |
| 06/26/2013 | EP2605655A1 Methods of treating mild cognitive impairment (mci) and related disorders |
| 06/26/2013 | EP2605652A1 Diketones and hydroxyketones as catenin signaling pathway activators |
| 06/26/2013 | EP2041124B1 Pyrazolealkanamide substituted thiophenes as ampa potentiators |
| 06/26/2013 | CN103180326A 杂环化合物及其用途 Heterocyclic compounds and their use |
| 06/26/2013 | CN103180321A Monohydrate of azaadamantane derivative |
| 06/26/2013 | CN103180319A Inhibitors of semicarabazide - sensitive amine oxidase |
| 06/26/2013 | CN103180315A Method of treatment for mental disorders |